DV
Dividend Vision

PRQR — ProQR Therapeutics BV

ProQR Therapeutics BV (PRQR)

Total return is -87.0% over the past 11.9 years, 457.5 points behind SPY at 370.5%. Its deepest 1-year drawdown was 55.1%.

PRQR is an equity stock focused on ProQR Therapeutics BV, a biotechnology company. The fund does not currently offer dividend distributions or a meaningful yield profile, and key metrics including expense ratio and assets under management are not available. This holding appeals primarily to growth-oriented investors seeking exposure to the biopharmaceutical sector rather than income investors.

PRQR key facts

Asset type
Stock
Asset class
Equity
Inception date
09/18/2014
Last close
$1.92
Market cap
$248,373,792
Average volume
487365.0
Beta
0.034
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.51